Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease May 24, 2021 08:30AM
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease May 24, 2021 08:30AM
Cassava Sciences (SAVA) PT Raised to 'Street High' $80 at Maxim Group Feb 16, 2021 08:09AM
Cassava Sciences (SAVA) Prices $75 Million Public Offering of Common Stock at $8/sh Nov 13, 2020 09:09AM
Cassava Sciences Announces Pricing of $75 Million Public Offering of Common Stock Nov 13, 2020 09:08AM


Nov 13, 2020 09:08AM Cassava Sciences Announces Pricing of $75 Million Public Offering of Common Stock
Sep 14, 2020 10:22AM Maxim Group Upgrades Cassava Sciences (SAVA) to Buy, AFter Pharma Study Results Released
May 15, 2020 11:52AM Maxim Group Downgrades Cassava Sciences (SAVA) to Hold
May 15, 2020 09:30AM Pre-Open Movers 05/15: (SRNE) (NEWR) (DENN) Higher; (SAVA) (JCP) (CODX) Lower (more...)
Jun 25, 2019 07:33AM Maxim Group Starts Cassava Sciences (SAVA) at Buy
Jun 18, 2019 08:30AM Cassava Sciences to Present at Maxim Group’s Conference on Alzheimer’s Disease
Jun 18, 2019 08:30AM Cassava Sciences to Present at Maxim Group’s Conference on Alzheimer’s Disease